It improves the TMZ chemotherapy response by ROS upregulation, indicating that Trim25-mediated ubiquitination of ITPKB may be an important regulatory mechanism in the pathogenesis and treatment of GBM. This evidence concerns the gene ITPKB and glioblastoma.